Summary
The prevalence of chronic HBV and HCV infection varies widely between European countries. Cost-effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV transmission.
Results hosted on duckduckgo.com
The prevalence of chronic HBV and HCV infection varies widely between European countries. Cost-effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV transmission.